The incretin effect is greatly affected in patients with type 2 diabetes, with the insulinotropic influence of the GIP hormone being diminished in pancreatic beta cells and the effect of GLP-1 reduced. This evidence concerns the gene GCG and type 2 diabetes mellitus.